Homocysteine management for Parkinson's patients on levodopa
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether controlling homocysteine levels can help people with Parkinson's disease who are taking levodopa. You may qualify if you take at least 300 mg of levodopa per day, are between 40 and 90 years old, and have no major kidney problems or uncontrolled high blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease by a doctor.
- You take levodopa (Sinemet or similar) at a dose of at least 300 mg per day.
- You are between 40 and 90 years old.
- Your kidney function is good (eGFR is 60 or higher).
- Your blood pressure is well-controlled (no uncontrolled high blood pressure).
- You do not use insulin for diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a substance in your blood called homocysteine relates to Parkinson's symptoms. If you join, you will have a blood test and assessments to help understand this link.
This trial tests if taking daily amino acid supplements helps people with Parkinson's disease. You need to be on stable Parkinson's medication for at least 3 months.
This trial tests whether a study medicine regimen can help prevent a first stroke in people with hard-to-control “high homocysteine” risk factors linked to a specific gene type. You may qualify if you have certain blood pressure levels, a specific MTHFR gene result, and related blood test findings.
This study tests whether a supplement called gamma-glutamylcysteine can increase levels of a natural antioxidant called glutathione in the brain of people with Parkinson's. If you are between 50 and 80 and have mild cognitive symptoms, this trial may help researchers understand a new way to support brain health.
This study tests whether taking vitamin D3 supplements can improve the nerve function that controls your heartbeat in men with Parkinson's disease who have low vitamin D levels. If you have mild to moderate Parkinson's and are on levodopa, this trial may help understand if vitamin D can support your heart health.
This trial tests whether zinc supplements can lower high homocysteine levels better than folic acid in people with chronic kidney disease who are on hemodialysis. It aims to find a simple, safe way to help protect your heart and blood vessels.
Hear when a new Parkinson&Amp;#39;s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.